Tags: adipocyte, cell biology, cell culture, oxygen consumptioncancer, cell biology, cell cannibalism, developmental biology, entosiscell biology, mouse brain, neuroscience, single-cell RNA sequencing, spatial transcriptomicsRegenerationStem cells
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | ||
| 2 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 3 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - about 1 month ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 4 months ago FDA OKs First Cellular Therapy for Melanoma - 9 months ago | |
| 4 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | ||
| 5 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 6 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 7 | Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England | ||
| 8 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | Is a better CAR-T cell therapy option on the horizon? - 4 months ago | |
| 9 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | ||
| 10 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Tisa-Cel Yields Durable Responses in R/R Follicular Lymphoma - 11 months ago |